Leap Therapeutics Inc reports results for the quarter ended in September - Earnings Summary

Cypherpunk Technologies

14/11/2022 13:51

* Leap Therapeutics Inc  LPTX.OQ  reported a quarterly
adjusted
loss of 13 cents​​ per share for the quarter ended in September.
The mean expectation of five analysts for the quarter was for a
loss of 12 cents per share.
    * Reported revenue was zero​; analysts expected zero. 
    * Leap Therapeutics Inc's reported EPS for the quarter was a
loss
of 13 cents​.
    * The mean earnings estimate of analysts had fallen by
about 13.2%
in the last three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Leap Therapeutics Inc shares had fallen by 28.9% this
quarter and lost 80.7% so far this year.
    * The company reported a quarterly loss of $15.09 million.
    * Wall Street's median 12-month price target for Leap
Therapeutics
Inc is $4.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 5 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated from Refinitiv data November
14 at 01:51 p.m.  ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2022      -0.12          -0.13          Missed
 Jun. 30 2022      -0.10          -0.15          Missed
 Mar. 31 2022      -0.10          -0.09          Beat
 Dec. 31 2021      -0.11          -0.10          Beat